Hemrajani Rekha sold MAXCYTE, INC. ($MXCT) shares once on the open market in the last year for a total of $22,378, with her most recent sale on June 25, 2025. She made no open market purchases. Her sales rank 10,976th among 11,678 insiders in our database, well below the average of $8.6 million per person across about 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Hemrajani Rekha | Not found | A | Stock option (right to buy) | 40400 | $0.00 | 40,400.0000 | 54,218,001 | 9999.99% | 0.07% |
| Sept. 10, 2025 | LB PHARMACEUTICALS INC | $LBRX | Hemrajani Rekha | Not found | A | Stock Option (Right to Buy) | 22449 | $0.00 | 22,449.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2025 | MAXCYTE, INC. | $MXCT | Hemrajani Rekha | Not found | S | Common Stock | 10684 | $2.09 | 39,893.0000 | 105,950,480 | 21.12% | 0.01% |
| June 18, 2025 | MAXCYTE, INC. | $MXCT | Hemrajani Rekha | Not found | A | Stock Option (right to buy) | 50790 | $0.00 | 50,790.0000 | 105,950,480 | 9999.99% | 0.05% |
| June 18, 2025 | MAXCYTE, INC. | $MXCT | Hemrajani Rekha | Not found | A | Common Stock | 29210 | $0.00 | 50,577.0000 | 105,950,480 | 136.71% | 0.03% |
| June 5, 2025 | BioAge Labs, Inc. | $BIOA | Hemrajani Rekha | Not found | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 35,850,037 | 9999.99% | 0.06% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | Hemrajani Rekha | Not found | P | Common Stock | 3000 | $18.00 | 3,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 21, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Hemrajani Rekha | Not found | A | Stock Option (right to buy) | 40400 | $0.00 | 40,400.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Hemrajani Rekha | Not found | P | Common Stock | 30000 | $1.55 | 33,000.0000 | 0 | 1000.00% | 0.00% |
| April 17, 2024 | BioAge Labs, Inc. | $BIOA | Hemrajani Rekha | Not found | A | Stock Option (Right to Buy) | 28497 | $0.00 | 28,497.0000 | 0 | 9999.99% | 0.00% |
| Sept. 25, 2024 | BioAge Labs, Inc. | $BIOA | Hemrajani Rekha | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Hemrajani Rekha | Not found | A | Stock Option (right to buy) | 20200 | $0.00 | 20,200.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | MAXCYTE, INC. | $MXCT | Hemrajani Rekha | Not found | A | Common Stock | 21367 | $0.00 | 21,367.0000 | 104,089,758 | 9999.99% | 0.02% |
| June 11, 2024 | MAXCYTE, INC. | $MXCT | Hemrajani Rekha | Not found | A | Stock Option (right to buy) | 40701 | $0.00 | 40,701.0000 | 104,089,758 | 9999.99% | 0.04% |
| June 22, 2023 | MAXCYTE, INC. | $MXCT | Hemrajani Rekha | Director | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 102,846,036 | 9999.99% | 0.05% |
| March 20, 2023 | MAXCYTE, INC. | $MXCT | Hemrajani Rekha | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 101,702,664 | 9999.99% | 0.04% |